Navigation Links
Stimulus Grant To Fund 'Whole-Genome Sequencing' In Children With Autism
Date:9/30/2009

National Institute of Mental Health awards $4.5 million to apply next-generation technology to finding autism's causes

BOSTON, Sept. 30 /PRNewswire-USNewswire/ -- Children's Hospital Boston, with the Broad Institute and Harvard Medical School, has been awarded a Grand Opportunity grant from the National Institute of Mental Health as part of the federal stimulus package, to pursue "whole-genome" sequencing of patients with autism, using new technologies for rapid DNA sequencing to better understand autism's causes. The roughly $4.5 million grant, part of the federal stimulus package, officially starts September 30. All genetic sequence data will be made publicly available.

Autism frequently runs in families, and is the most highly genetic of neuropsychiatric disorders. About a dozen specific genes and mutations have been discovered, including several by researchers at Children's. Yet these genes still leave unexplained the vast majority of autism cases -- about 85 percent, says Christopher A. Walsh, MD, PhD, chief of genetics at Children's Hospital Boston, who is leading the new initiative with co-investigators Michael Greenberg, PhD, head of Neurobiology at Harvard Medical School, and a team at the Broad Institute of MIT and Harvard, led by Stacey Gabriel, PhD, and David Altshuler, MD, PhD.

The project will first focus on 85 Middle Eastern patients, previously studied in Walsh's lab, whose parents share common ancestry and who have recessive forms of autism. These patients make good initial subjects for study because linkage analyses of their extended families have already narrowed the field of candidate mutations down to just 1 percent of their genome. Because autism is extremely variable genetically, rare large families with multiple affected individuals provide a good opportunity for mapping disease-causing genes, many of which also occur in autism patients generally.

As techniques are r
'/>"/>

SOURCE Children's Hospital Boston
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sevocity EHR 08 Released With ARRA (Stimulus) Commitment
2. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
3. MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie
4. Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement
5. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
6. Lilly Endowment Awards $7 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County, IN
7. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
8. Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
9. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
10. Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness
11. Hyland Software Provides Grant Assistance to Kick-Start Technology Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB ... Industrialized Countries , , - A third ... impacts their enjoyment of the festive ... find shopping for gifts, preparing ... difficult to do, - ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
(Date:12/11/2009)... SAN DIEGO, Dec. 11 Ambit Biosciences Corporation ... of Texas M. D. Anderson Cancer Center of the ... 220 Monotherapy E fficacy) Phase 2 ... myeloid leukemia (AML). AC220 is a novel, orally ... specifically designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... , , , , , , Cells ... General , Keep an eye on your cells; ensure they are ... beginning to, the end of transfection. , , ... Dividing cells tend to be more accessible for uptake and expression of, foreign ...
... , , , , , ... expression profiling technology. Agencourt offers , a cost-effective outsourcing solution for ... technology more accessible to researchers. Agencourt's , SAGE sequencing service provides ... Rapid turnaround , , ...
... , , , , ... system that can be completed in less than 15 minutes. , ... plasmid DNA directly from overnight cultures, which can improve ... by as much as a full day. SprintPreps , ...
Other Biology Technology:General Considerations for Successful Transfection Experiments 2SAGE & LONGSAGE SEQUENCING 2SPRINTPREP SINGLE STEP PLASMID PURIFICATION 2SPRINTPREP SINGLE STEP PLASMID PURIFICATION 3
(Date:12/14/2009)... of researchers from the Astrobiology Centre (INTA-CSIC) has shown ... to the formation of the most basic biological molecules ... order to carry out this study, published in the ... the chemical conditions of the early Earth. , "We ... ammoniac solutions it produces hydrogen cyanide, a substance that ...
(Date:12/14/2009)... WAYNE, Pa., Dec. 14 MODA Technology ... monitoring (EM), utility and product testing for the ... MODA 3.0, the company,s third generation mobile data ... (QC) organizations to further automate their regulated manufacturing ... new capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 1Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 2Microbridge Technologies Announces Micro Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications 48144 1Microbridge Technologies Announces Micro Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications 48144 2Microbridge Technologies Announces Micro Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications 48144 3Generic Erosion Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by 241 8 Billion from 2008 to 2018 48141 1Generic Erosion Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by 241 8 Billion from 2008 to 2018 48141 2
... the causes and treatment of asthma and Chronic Obstructive ... drugs to battle these debilitating conditions. , The ... awarded a total of 1.24m in grants to study ... Knox and Dr Linhua Pang 700,000 to research transcriptional ...
... and livestock producers have created a symbiotic relationship. Cattle ... the ethanol distilling process, giving ethanol producers have an ... Kansas State University has found that cattle fed distiller,s ... in their hindgut. This particular type of E. coli ...
... NY -- Confused about the right planting depth for ... some flower bulbs are actually "smart" enough to adjust ... published in the Journal of the American Society for ... position by moving deeper into the ground, apparently in ...
Other Biology News:HATS off to combat asthma 2K-State researchers findings on E. coli 2'Smart' flower bulbs pull themselves to deeper ground 2
This STAT antibody sampler pack contains 8 monoclonal ,STAT antibodies....
Kanamycin is used for selection of resistant bacteria. C18H36N4O11xH2SO4. Contains 10 mg/ml kanamycin (base) utilizing kanamycin sulfate in 0.85% saline....
...
...
Biology Products: